Metabolic plasticity in response to environmental or hormonal cues, such as high fat diets or changes in temperature, or hormones, has been identified as a hallmark feature of brown adipose tissue (Galic et al., 2010). Besides the plastic response of WAT beiging, which is the generation of brown-like adipocytes in white adipose depots, diet-induced obesity in mice evokes vascular remodeling and functional hypoxia in BAT leading to a whitening phenotype, characterized by mitochondrial dysfunction and loss, lipid droplet accumulation, and decreased expression of thermogenic markers (Shimizu et al., 2014b). BAT whitening is associated to decreased thermogenic capacity and impaired energy balance of this tissue, while WAT beiging increases thermogenesis in this depot.
Beiging
Though beiging in rodents is classically studied in subcutaneous depots, it may also occur, depending on mouse strain, in visceral depots such as mesenteric, periaortic, mediastinal or perirrenal depots (Vitali et al., 2012). Brown but not white or beige adipocytes derive from myogenic factor 5 (Myf5)-expressing precursors and therefore share a common lineage with skeletal myocytes (Crisan et al., 2008;Kajimura and Saito, 2014). Beige adipocytes, on the other hand, originate from the lineage of Myf5-negative cells, and are conceived as inducible or recruitable brown adipocytes within WAT.
Beige adipocytes may derive de novo from endothelial and perivascular cells (Lee et al., 2012;Tran et al., 2012), but are mainly originated by transdifferentiation of white Myf5-negative adipocytes (Barbatelli et al., 2010). Beiging of WAT is under the control of various key transcription factors, such as PGC-1α, C/EBPa, PPARg, and PRDM16 (Seale et al., 2009), and the central nervous system is paramount in fat beiging (Bi and Li, 2013;McGlashon et al., 2015).
The recruitment of brown-like adipocytes within subcutaneous depots induced by cold, stress or HFD (Garcia-Ruiz et al., 2015;Kurylowicz and Puzianowska-Kuznicka, 2020;Wu et al., 2012) favors resistance to HFD-induced obesity due to enhanced energy expenditure and increased metabolic rate at the expense of smaller WAT depots (Kajimura et al., 2015) (Kurylowicz and Puzianowska-Kuznicka, 2020), and has therefore garnered particular interest in obesity studies for its calorie burning potential.
Whitening
In contrast to beiging which occurs in WAT, whitening is a phenomenon evidenced mainly in BAT, though it also may occur in beige adipocytes. Physiological inactivation of brown/beige adipose tissues by the whitening process is observed during obesity, aging, lactation, or increased environmental temperature, playing autophagy a central role in this process (Altshuler-Keylin et al., 2016;Bartke et al., 2021;Cairo et al., 2019;Darcy and Tseng, 2019;Gospodarska et al., 2015). The shift from cold to thermoneutral temperature in mice triggers massive loss of protein content in brown and beige adipocytes due to an adaptive decrease in thermogenic activity (Gospodarska et al., 2015). Beige adipocytes within WAT “disappear” when returning to thermoneutrality: they lose their multilocular phenotype and UCP1 expression. Conversely, BAT inactivation includes protein degradation, protein synthesis inhibition, and lipid accumulation, even though brown adipocytes do not disappear. In obese subjects, or HFD-fed rodents, an increase in BAT weight may be found, explained by higher lipid content, and a reduction in the thermogenic function of the tissue. In this sense, heavier BAT depots do not necessarily indicate a greater thermogenic capacity but are associated with a defective tissue, as triglycerides are stored instead of being used for heat production (Shimizu et al., 2014b).
During BAT whitening, cells with multilocular lipid droplets evolve to unilocular cells, resembling white adipocytes. There is a proneness to tissue inflammation and adipocyte death (Kotzbeck et al., 2018). Tissue inflammation leads to macrophage infiltration, and the appearance of crown like structure formations, enlarged endoplasmic reticulum, cholesterol crystals, degenerating or dysfunctional mitochondria, decreased lipid oxidation and increased collagen fibrils (Kotzbeck et al., 2018). Importantly, reduced insulin stimulated glucose uptake by BAT can be found, suggesting insulin resistance of the tissue (Kuipers et al., 2019;Roberts-Toler et al., 2015). A reduced uptake of triglycerides derived from FFA, and marked reduction of thermogenic biomarkers are also key features of whitening. As a result, thermogenesis is compromised and the ability to maintain body temperature when exposed to cold is impaired.
The whitened brown adipocytes still retain some brown like typical mitochondria, and weak UCP1 expression, suggesting a conversion of brown to white in stressful conditions such as lipid overload, or inhibition of oxidation (Cinti, 2009;Giordano et al., 2014). Even so, de novo white adipocyte formation, and infiltration of adjacent white adipocytes, usually found in the periphery of BAT lobules, have been suggested as contributing factors.
Multiple causes contribute to the whitening of brown adipocytes, and in some mouse models the phenotype can be even evidenced macroscopically at necropsy. Among these factors are long and short term HFD (Kuipers et al., 2019;Roberts-Toler et al., 2015;Shimizu et al., 2014b), high ambient temperature (Kotzbeck et al., 2018), leptin receptor deficiency (Kotzbeck et al., 2018), impairment of adrenergic signaling (Kotzbeck et al., 2018), lipase deficiency (Kotzbeck et al., 2018), deficient BAT vascularization (Shimizu et al., 2014a), and increased autophagy (Deng et al., 2020).
Genetic ablation or overexpression of different genes yield important information to unravel the participating mechanisms. For example, BAT whitening is found in different transgenic mice such as the adipose triglyceride lipase knockout mouse (Atgl-/-) (Kotzbeck et al., 2018), mice lacking beta-adrenergic receptors (beta-less) (Kotzbeck et al., 2018), the obese db/db (Kotzbeck et al., 2018), the adipose Vegf knockout mouse (Shimizu et al., 2014a), mice with adipocyte specific loss of scaffold protein p62 (Muller et al., 2013), and mice overexpressing the Carbohydrate response element-binding protein b (Chrebpb) in BAT tissue (Wei et al., 2020). It can be therefore inferred that adipose Atgl expression and its normal lipolytic action are needed to provide fatty acids as initial fuel for thermogenesis, preventing whitening. Furthermore, correct B-adrenergic signaling, and Vegf induced vascularization (Kotzbeck et al., 2018;Shimizu et al., 2014a) are paramount in shaping a healthy brown adipocyte. The scaffold protein p62 is necessary for adequate mitochondrial biogenesis and function (Muller et al., 2013), and adequate levels of Chrebpb (Wei et al., 2020), a key transcription factor regulating de novo lipogenesis, prevents whitening (Deng et al., 2020). Finally, in the lacDrdKO mouse which is hyperprolactinemic (Luque et al., 2016), massive whitening and decreased Ucp1 expression in BAT point to an action of this hormone on BAT plasticity (Lopez-Vicchi et al., 2020b).
The occurrence of whitening in response to exogenous compounds may be involved in their capacity to induce obesity. And therefore the inhibition of this process is a promising target in the treatment or prevention of obesity. For example, glucocorticoids which induce obesity, decrease BAT UCP1 expression and hinder thermogenesis in rodents (Deng et al., 2020;Mousovich-Neto et al., 2019). In humans they acutely increase or chronically suppress BAT activity (Ryu et al., 2015). In this respect, it has been shown that dexamethasone induces BAT whitening in vivo and in vitro (Deng et al., 2020) decreasing thermogenic markers, and increasing the expression of WAT markers within brown adipocytes. This effect has been related to whitening due to enhanced autophagy, mediated by the antiproliferative gene B cell translocation gene 1 (Btg1). Therefore, knocking down either Btg1 or the autophagy related gene Atg7 prevented the whitening effect induced by dexamethasone (Deng et al., 2020).
Whitening may also add to the deleterious effects of organic contaminants. Such is the case of Dechloran Plus (DP) a polychlorinated organic molecule, used in cable coating, electrical wires, computer connectors and plastic roofing materials (Zheng et al., 2014), which promotes BAT whitening, reduces UCP1 expression and induces BAT dysfunction (Peshdary et al., 2020).
On the other hand, fenofibrate, an agonist of peroxisome proliferator-activated receptor a (PPARa), countered the whitening induced in BAT by HFD, improving thermogenesis, increasing UCP1, inducing mitochondrial biogenesis, and stimulating the SNS and its downstream effectors (Miranda et al., 2020), positioning the PPARa pathway as a therapeutic target to decrease whitening and enhance BAT function.